MBX Biosciences

IPO

Precision Therapeutics. Simplified Disease Management.

MBX Biosciences is a healthcare company in Carmel, United States, founded in 2018. It has raised $228.1M across 4 rounds, most recently a $63.5M Series C in August 2024.

Headquarters
Carmel, Indiana
Employees
11–50
Founded
2018
Business Model
B2B
Website
mbxbio.com
Total Funding
$228.1M
Last Round
$63.5M Series CAug 2024
Rounds
4
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 12 investors for this company. to use credits for reveals, or explore the API.

About

MBX Biosciences is pioneering Precision Endocrine Peptide (PEP) therapeutics for patients with endocrine and metabolic disorders. Its pipeline includes MBX 2109 (Phase 2, hypoparathyroidism), MBX 1416 (Phase 1, post-bariatric hypoglycemia), and pre-clinical obesity programs. The company went public on Nasdaq (MBX) in September 2024.

Funding & Exit History

Data from Indexed.vcUpdated
IPOSep 2024
$163.2M

4 more events

  • Series C20245 investors
  • Series B20221 investor
  • Series A20204 investors

Funding: Seed through Series C. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Backend ×1
  • Cloud/Infrastructure ×1
  • Frontend ×1
  • Marketing & SEO ×1
  • Other ×1
  • Productivity & Collaboration ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024
Inizio

Inizio helps health and life sciences clients realize product potential through deep expertise, g...

New York, United States10001+Healthcare
Venture RoundTotal funding$4.4B

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

MBX Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/mbx-biosciences"><img src="https://indexed.vc/api/badge/company/mbx-biosciences" alt="MBX Biosciences on Indexed.vc" width="260" height="76" /></a>